Peanut allergic
Background: Peanut allergy (PA) is a life-threatening condition that lacks regulator-approved treatment. Regulatory T type 1 (T R 1) cells are potent suppressors of immune responses and can be induced in vivo upon repeated antigen exposure or in vitro by using tolerogenic dendritic cells. Whether oral immunotherapy (OIT) leads to antigen-specific T R 1 cell induction has not been established. Objectives: We sought to determine whether peanut-specific T R 1 cells can be generated in vitro from peripheral blood of patients with PA at baseline or during OIT and whether they are Food allergies are an important health issue in developed countries, with a prevalence of 8% among children. 1 Peanut allergy is one of the most common food allergies, affecting 1% to 2% of children and 0.6% of adults in developed countries. 2 As of today, there is no regulatory-approved treatment for PA, and exposure to trace amounts of the allergen can lead to a potentially fatal anaphylactic reaction. 3 Management of the disease consists of avoidance of the allergen, which is difficult to achieve, and patients are at risk of accidental exposure to the allergen.
Oral immunotherapy (OIT) is a promising experimental therapy for food allergies. It consists of the ingestion of small and increasing doses of the allergen during a buildup phase that is immediately followed by daily ingestion of a target amount of the allergen during a maintenance phase that can last for several years. [4] [5] [6] Even though OIT shows encouraging results and might improve the patient's quality of life, it carries important risks of adverse reactions. Taken together, these results illustrate a need to improve the safety and efficacy of OIT. 7, 8 Immunologic tolerance, which is defined as a state of antigenspecific unresponsiveness, is established through different mechanisms that include anergy, exhaustion, and active suppression prompted by regulatory T cells. 9, 10 In particular, T-cell anergy corresponds to the lack of a functional response after exposure to the cell's cognate antigen. [11] [12] [13] Antigen-specific T-cell anergy can be induced in the presence of IL-10 during primary antigen stimulation in vitro.
14 IL-10-anergized T cells have impaired secondary responses to the same antigen, and T-cell cloning of these anergic cells allows the isolation of IL-10-producing regulatory T type 1 (T R 1) cells. 15 Regulatory T cells are essential contributors to the maintenance of peripheral immunologic tolerance. [16] [17] [18] [19] Forkhead box P3 (FOXP3)
1 thymus-derived regulatory T cells are well-studied CD4
1 regulatory T cells involved in regulation of immune responses toward self-antigens, although the demonstration of their antigen specificity in vivo and their generation in vitro toward specific antigens has been challenging. 20 T R 1 cells are a subset of CD4 1 regulatory T cells distinct from FOXP3
1 regulatory T cells. They are generated toward different antigens encountered in the periphery, including alloantigens in transplanted patients who achieved tolerance, 21 gliadin in patients with celiac disease, 22 and bee venom in beekeepers. 23 T R 1 cells can be generated in vitro toward different antigens in the presence of IL-10 independently of the expression of FOXP3. 24 T R 1 cells are identified by coexpression of the surface markers CD49b and lymphocyte-activation gene 3 (LAG3). 25 IL-10-anergized or polarized T-cell cultures and peripheral blood of transplanted patients who achieved tolerance are enriched in CD49b 1 LAG3
1
T R 1 cells. T R 1 cells produce high levels of IL-10, low levels of IL-2, no IL-4, no IL-17, and variable amounts of IFN-g. 15, [25] [26] [27] The suppressive properties of T R 1 cells are primarily mediated by IL-10, and before identification of the specific T R 1 surface markers CD49b and LAG3 in 2013, T R 1 cells were often referred to as hyporesponsive (ie, anergic) cells or IL-10-producing CD4 1 T cells.
T R 1 cells regulate both the innate and adaptive responses underlying allergic reactions by acting on eosinophils, basophils, mast cells, and T H 2 cells. 28, 29 Allergic subjects present disproportionate T H 2 responses to innocuous antigens 30, 31 and defects in IL-10-producing regulatory T cells that result in an in vivo imbalance between regulatory T-cell and T H 2 populations. 23, 29, 32, 33 The intestinal mucosa is the initial site of interaction between immune cells and dietary antigens and therefore plays a crucial role in the maintenance of immunologic tolerance to foods. 34 Gliadinspecific T R 1 cells that possess highly suppressive properties have been isolated from the intestinal mucosa of patients with celiac disease in remission. 22 In addition, repeated ingestion of a specific antigen is responsible for the expansion of IL-10-secreting cells in the gut in mice, 35 but it remains to be determined whether similar mechanisms occur in human subjects. Reinforcing this concept, our group published preliminary findings in a limited patient population, which indicate that peripheral CD49b

LAG3
1 T R 1 cells are present at higher frequencies in peripheral blood of patients undergoing OIT compared with untreated patients, but no functional data were obtained at that time. 33 Based on the established role of T R 1 cells in immunomodulation and regulation of allergic responses in vivo, we hypothesize that peanut-specific T R 1 cells could be generated from healthy control (HC) subjects but not from untreated patients with peanut allergy (PA). As a corollary, we further hypothesized that OIT could favor T R 1 cell differentiation through chronic exposure to low doses of the allergen in the gut and that peanut-specific T R 1 cells could be generated at higher frequencies from patients with PA undergoing OIT compared with untreated subjects. Our group has previously published that antigen-specific T R 1 cells can be induced in vitro using tolerogenic dendritic cells (DC-10s). 36 In particular, functional Der p 2-specific T R 1 cells that present antigen-specific anergy and suppressive activities in vitro can be induced from patients allergic to house dust mite. 37 In this study we tested whether T R 1 cells could be induced in vitro using DC-10s pulsed with the main peanut allergens Arachis hypogaea, Ara h 1 and 2 (CD4 
1 T R 1 cells can be induced from all 4 groups. Despite their peanut antigen specificity, pea-T10 cells from patients with PA of all 3 groups were not anergic on secondary peanut stimulation and produced high levels of T H 2 cytokines, whereas all pea-T10 cells from HC subjects showed anergy and significantly reduced T H 2 cytokine production.
METHODS
Study subjects
This study included 21 patients with PA (median age, 15.1 6 9.8 years) confirmed by double-blind, placebo-controlled oral food challenges and 7 HC subjects (median age, 16 6 3.3 years) from the institutional review boardapproved protocol 5136 at Stanford University School of Medicine. Seven patients with PA had not undergone OIT (baseline), 7 had been undergoing OIT for more than 3 months and less than 1 year (ST-OIT), and 7 had been undergoing OIT for more than 3 years (LT-OIT). No withdrawal of maintenance daily peanut therapy had occurred in any of the OIT groups. Clinical reactivity was defined as any sign of allergic reaction (ie, score >1 on the Bock criteria 38 ) upon ingestion of the allergen. The clinical symptoms and demographics of the patients with PA are presented in Table I . Written informed consent was obtained for all participants before entering the study.
For more information on dendritic cell differentiation, T-cell differentiation, Ara h 1/2 antigen specificity assay and cytokine detection, flow cytometry, and statistical analyses, see the Methods section in this article's Online Repository at www.jacionline.org.
RESULTS
Peanut-specific T R 1 cells can be induced from HC subjects and patients with PA by using pea-DC-10s DC-10s and mature dendritic cells (mDCs) were differentiated from peripheral blood of HC subjects and patients with PA by using previously published methods and pulsed with Ara h 1 and 2. 36, 37 The experimental scheme is shown in Fig E1, A, in this article's Online Repository at www.jacionline.org. Both peanutloaded DC-10 (pea-DC-10) and pea-mDCs from HC subjects and patients with PA expressed high levels of CD11c and CD86 (Fig 1) , showing that the cells displayed a mature myeloid phenotype. DC-10s remained CD14 1 , whereas mDCs were CD14 2 ( Fig  1) . CD11c, CD86, and CD14 expression in pea-DC-10s or peamDCs were comparable between HC subjects and all 3 cohorts Pea-T10 cells were generated using pea-DC-10s in the presence of IL-10 to induce anergy and T R 1 cells from autologous CD4
1 T cells obtained from HC subjects and patients with PA, as previously described (see Fig E1, A) . 37 Control CD4 1 T cells coincubated with mDCs pulsed with the main peanut allergens (pea-Tm cells) were generated in the absence of IL-10. At the end of both cultures, we checked CD25 expression within the CD4
1
CD45RA
2 memory population as an indicator of the activation state of the cells. Overall, CD4
1
CD45RA
2 T cells from HC subjects showed lower percentages of CD25
1 cells compared with CD4
1
CD45RA
2 T cells from patients with PA (31.2% vs 38.1%, respectively; P 5 .0454; see Table E1 in this article's Online Repository at www.jacionline.org); pea-Tm cells from patients with PA showed higher percentages of CD25
1 cells compared with pea-Tm cells from HC subjects (28.2% 6 6.7% vs 38.1% 6 12.7%, respectively; P > .05; see Fig E3, A and B, in this article's Online Repository at www.jacionline.org), indicating that peanut-specific activation was overall higher in patients with PA than in HC subjects. The percentage of CD25 1 cells was comparable between all 3 cohorts of PA patients (see Fig E3, C) .
Pea-T10 cells of both HC subjects and patients with PA contained a higher frequency of CD49b
1
LAG3
1 T R 1 cells compared with pea-Tm cells (CD49b
1
LAG3
1 percentage for pea-T10 cells of HC subjects was 7.4% 6 3.7% vs 2.6% 6 3% for pea-Tm cells [ Fig 2, A and B, and see Table E1 ; P 5 .0156]; percentage for pea-T10 cells of patients with PA was 9.0% 6 4.3% vs 2.9% 6 1.0% for pea-Tm cells [Fig 2, A-C, and see Table E1 ; P < .0001]). There was no statistical difference in the percentage of CD49b Table E1 ). In addition, there was no statistical difference in the percentage of CD49b 1 LAG3 1 T R 1 cells present in the pea-T10 cells of the 3 cohorts of patients with PA (CD49b
1
LAG3
1 T R 1 cells for pea-T10 cells of baseline patients with PA 5 8.6% 6 2.7%; for ST-OIT PA patients 5 9.4% 6 6.2%; and for ST-OIT PA patients 5 8.8% 6 3.9%; P > .05; Fig 2, E) . Altogether, the frequency of CD49b 1 LAG3
1
T R 1 cells induced by pea-DC-10s was similar in HC subjects and patients with PA, irrespective of the presence and duration of OIT. Peanut-specific hyporesponsiveness can be achieved in pea-T10 cells of HC subjects but not in those of patients with PA
To test whether pea-T10 cells were hyporesponsive to a secondary stimulation with the same antigen (ie, anergic) compared with pea-Tm cells, we measured proliferative responses by means of carboxyfluorescein succinimidyl ester dilution after 4 or 5 days of secondary stimulation with pea-mDCs (Fig 3, A and B, and see Figs E1 , B, and E4, A, in this article's Online Repository at www.jacionline.org). We considered pea-T10 cells to be anergic when their proliferative response to the antigen was lower than the proliferative response of pea-Tm cells. Pea-T10 cells from all HC subjects were anergic. Pea-T10 cells of 6 of 7 HC subjects presented anergy of greater than 67%, and 1 HC subject presented anergy of 32% (mean anergy HC, 69%; range, 32% to 87%; Fig 3, A and B, and see Fig E4, A) , with an overall proliferation to peanut antigens significantly higher in pea-Tm cells than in pea-T10 cells (P 5 .0156). In contrast, pea-T10 cells of only 9 of 21 patients with PA were anergic (mean anergy in patients with PA 5 34.3%; range, 5% to 80%; Fig 3, A and B, and see Fig E4, A) , and only 2 of 21 patients with PA presented anergy of greater than 67%, a level of anergy that we previously established to be acceptable for clinical purposes.
39,40
The ratio of proliferation of pea-Tm to pea-T10 cells was greater in HC subjects versus patients with PA (P 5 .0007; Overall, there was no statistically significant difference in the pea-Tm/pea-T10 cell proliferation ratio between any of the 3 PA cohorts, although we observed a trend toward higher pea-Tm/ pea-T10 cell proliferation ratio in LT-OIT PA patients (P > .05; Fig 3, D, and see Fig E4, C) . The pea-Tm/pea-T10 cell proliferation ratio was significantly lower in the LT-OIT cohort compared with that in HC subjects (P 5 .0262). Of note, there was no correlation between the age of the subjects in the study, the severity of the peanut allergy, the duration of OIT, and the induction of anergy.
We next tested whether anergy of pea-T10 cells was peanut specific by measuring proliferation elicited by a different antigen not present during primary stimulation, such as tetanus toxoid (TT). We found that proliferation upon restimulation with TTmDCs was comparable in pea-Tm and pea-T10 cells of both HC subjects and patients with PA (P > .05; see Fig E4, D and E), confirming that when present, hyporesponsiveness was only toward the peanut antigens used in the primary stimulation. Altogether, these results indicate that anergy toward peanut antigens could be induced by pea-DC-10s from HC subjects but not from PA cohorts, irrespective of OIT.
Because T R 1 cells from patients with PA were not able to anergize pea-T10 cells, we analyzed their cytokine secretion profile upon peanut-specific restimulation (see Fig E1, B) . Pea-T10 cells of HC subjects restimulated with pea-mDCs secreted significantly less IL-4 (23.4 6 19.3 pg/mL, P 5 .03; Fig 4, A, left panel, and see Table E1 ) and less IL-5 (123.1 6 67.6 pg/ mL, P 5 .034; Fig 4, B, left panel, and see Table E1 ) than control pea-Tm cells (49.9 6 32.7 and 408.5 6 118.2 pg/mL, respectively). Conversely, pea-T10 and pea-Tm cells of patients with PA secreted comparable amounts of IL-4 (343.5 6 358.7 and 447 6 449.6 pg/mL, respectively, P > .05; Fig 4, A, middle panel, and see Table E1 ) and IL-5 (784.2 6 534.8 and 1024 6 556.4 pg/ mL, respectively, P > .05; Fig 4, B, middle panel, and see Table  E1 ), and levels of both cytokines were greater than those produced by cells from HC subjects (Fig 4, right panels) . Pea-Tm and pea-T10 cells of HC subjects secreted comparable amounts of IL-10 (P > .05; see Fig E5, A, and Table E1 in this article's Online Repository at www.jacionline.org), whereas pea-Tm cells of patients with PA secreted more IL-10 compared with pea- (Fig 2, B) and patients with PA (Fig 2, C) Table E1 ). Pea-Tm and pea-T10 cells of both HC subjects and patients with PA secreted comparable amounts of IFN-g (P > .05; see Fig E5 , B, and Table E1 ), whereas pea-T10 cells of patients with PA secreted more IL-10 compared with pea-T10 cells of HC subjects (P 5 .0365; see Fig E5, A) . Interestingly, we observed a negative correlation between the levels of IL-4 and IL-5 produced by the pea-T10 cells and the percentage of anergy (P 5 .0145, r 5 20.5509, and (Fig 3, D) . Bas, Baseline. Each symbol represents a single experiment.
of T H 2 cytokines in HC subjects but not in patients with PA. In pea-T10 cells of patients with PA, responsiveness to the peanut antigens remains higher than in HC subjects, and it could not be affected by the addition of IL-10. These data suggest that pea-T R 1 cells from patients with PA either lack antigen specificity or are functionally defective.
Peanut-specific cells are enriched in CD49b 1 LAG3
1
T R 1 cells
We next tested whether the general lack of anergy in pea-T10 cells from patients with PA was due to lack of antigen specificity in the T R 1 cell population. Pea-T10 cells were restimulated with pea-mDCs, and the expression of the activation markers CD69 and CD137 41 was quantified in the CD45RA 2 memory and CD49b
1
LAG3
1 T R 1 cell populations (Fig 5, A and B , and see Fig E1, B) . Background expression of CD69 and CD137 from unstimulated pea-T10 cells was subtracted to account for the antigen-specific response. CD69
1 cells were more abundant within the T R 1 cell subset than within the total memory population (mean percentage of CD69 1 cells in T R 1 cells 5 28.3% 6 15.9%; memory cells 5 16.4% 6 12.1%; P 5 .0022; Fig 5, C , and see Table  E1 ). Similarly, the percentage of CD137 1 cells was higher within the T R 1 cell subset than in the total memory population (26.0% 6 20.8% and 8.3% 6 5.4%, respectively, P 5 .0044; Fig 5, D , and see Table E1 ). However, when the pea-T10 cells were restimulated with TT-mDCs, there was no difference in percentages of CD69 1 and CD137 1 cells in the T R 1 cell subset compared with the memory population (see Fig E6 in this article's Online Repository at www.jacionline.org). These data suggest that despite the lack of anergy, peanutspecific T R 1 cells are present in pea-T10 cells of patients with PA and more abundant than in the total memory population.
Because homing cues are essential for migration of T cells to tissues, we tested whether pea-T R 1 cells specifically express molecules that confer gut-homing properties. Expression of the guthoming receptor GPR15 42, 43 was significantly greater in the memory population of pea-T10 cells from both HC subjects and patients with PA (mean percentage of GPR15 1 cells in T R 1 cells 5 9.7% 6 7.7%; memory cells 5 5.3% 6 4.0%, P < .0001; Fig 6, A, and see Table E1 ). Expression of CCR9, a chemokine receptor that supports migration of T lymphocytes to the small intestine and colon, 44 was also greater in the CD49b
1
LAG3
1 T R 1 cell subset compared with that of the total memory population of pea-T10 cells from HC subjects and patients with PA (mean percentage of CCR9 1 cells in T R 1 cells 5 33.1% 6 18.3%; memory cells 5 19.7% 6 15.6%; P < .0001; Fig 6, B , and see Table E1 ). Altogether, these data indicate that peanut-specific T R 1 cells induced in vitro express gut-homing receptors, suggesting that they could have the capacity to migrate to the gut mucosa in both HC subjects and patients with PA.
DISCUSSION
In the current study we show that CD4 
LAG3
1 T R 1 cells specific for the main peanut allergens Ara h 1 and 2 can be induced in vitro from CD4
1 T cells of both HC subjects and patients with PA J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 1 by using tolerogenic DC-10s as antigen-presenting cells. Pea-T10 cells from HC subjects (containing 7.4% 6 3.7% pea-T R 1 cells) are anergic on antigen-specific rechallenge, whereas pea-T10 cells from patients with PA (containing 9.2% 6 4.8% pea-T R 1 cells) are not anergic, and they present high peaspecific proliferative responses. In addition, we found that the lack of anergy of pea-T10 cells in patients with PA was not significantly modified by the presence or duration of OIT. Indeed, we only observed a trend toward induction of anergy in pea-T10 cells of LT-OIT PA patients. Pea-T10 cells of HC subjects produce significantly less IL-4 and IL-5 versus control pea-Tm cells, but pea-T10 cells of patients with PA secrete similar levels of these T H 2 cytokines compared with pea-Tm cells. The absence of anergy observed for pea-T10 cells of patients with PA was not due to lack of antigen specificity in the T R 1 population. In addition, T R 1 cells induced in vitro express higher levels of the guthoming receptors GPR15 and CCR9 compared with the total memory population, suggesting preserved gut-homing capacity. Our study is the first to show that peanut-specific CD49b 1 LAG3 1 T R 1 cells can be induced in vitro from CD4 1 T cells of both HC subjects and patients with PA. Downregulation of peanut-specific allergic responses has been achieved in vivo in an allergic mouse model by using peanut-coated nanoparticles, which are known to favor T R 1 cell differentiation. 45, 46 In addition, gliadin-specific T R 1 cells have been isolated from the guts of patients with celiac disease in remission. 22 These studies support the role of T R 1 cells in maintenance of tolerance to food antigens and the rationale for inducing pea-T R 1 cells in vitro and testing their inhibitory function.
The ability to induce allergen-specific anergy and downregulate T H 2 cytokines has previously been demonstrated in PBMCs isolated from patients allergic to house dust mites. The authors showed that DC-10s are potent inducers of anergic cells specific for the aeroallergen Der p 2 in vitro. The level of anergy described toward Der p 2 was comparable with the level we observed in cultures of cells from HC subjects toward Ara h 1/2, which is also comparable with the minimum percentage of anergy of 67% that is required for the clinical use of IL-10-anergized T cells. 39, 40 However, in the Der p 2 study the presence of CD49b
1
LAG3
1 T R 1 cells in anergic cultures was not quantified because these biomarkers of T R 1 cells were reported later. 25 Using CD49b and LAG3 as bona fide markers of T R 1 cells, we clearly demonstrate that T R 1 cells can differentiate in vitro in an antigen-specific manner, but unlike in HC subjects, their presence is not associated with anergy in T cells of patients with PA. Indeed, anergy of greater than 67% was observed for only 2 patients in our cohort. Because the percentage of Ara h 1/2-specific cells in peripheral blood is low for both HC subjects and patients with PA (<1% of CD4 1 T cells 13,47 ), we were not able to test the suppression of primary proliferation or suppression of cytokine production by pea-T10 cells in vitro. However, acquisition of anergy and induction of T R 1 cells have been consistently described as a consequence of antigen-specific priming in the presence of IL-10. Our results suggest that there is an underlying defect in patients with PA that prevents induction of functional peanut-specific T R 1 cells in IL-10-dependent tolerogenic conditions. Typically, CD4 1 T cells from allergic patients present an abundant allergen-specific T H 2 population that likely results in an imbalance in the T R 1/T H 2 ratio skewed toward a T H 2 response. 30, 32, 48 We cannot exclude that functional peanutspecific T R 1 cells were induced in our culture system, but their numbers were not sufficient to dampen the proliferation and cytokine production of the pre-existing memory T H 2 cell population. Indeed, 1 patient receiving ST-OIT with severe PA for whom a very high percentage (21.6%) of T R 1 cells was induced in pea-T10 cells also presented very high anergy (80%), indicating that the T R 1 cells were functional and that high numbers of T R 1 cells might be required to downregulate the response of a pre-existing peanut-specific T H 2 memory population. Our data show that high IL-10 production does not correlate with induction of an anergic phenotype induced in vitro by means of allergen stimulation in tolerogenic conditions (IL-10 and DC-10s) but is associated with high amounts of IL-4 and IL-5 T H 2 cytokines in patients with PA, suggesting that IL-10 is produced by T H 2 cells.
Whether chronic antigen exposure through peanut OIT potentiates the function of T R 1 cells remains to be clarified. Although not statistically significant, we observed a trend toward induction of anergy for the pea-T10 cells of patients with PA who had been undergoing OIT for several years. Once confirmed in a larger number of patients, these data would be suggestive of the effect of LT-OIT, as we previously observed. 33 Persistent antigen exposure favors T R 1 induction and antigen-specific hyporesponsiveness, as broadly demonstrated in vitro and in vivo in both mouse and human studies. 21 Repetitive intraperitoneal injection of anti-CD3 antibodies induces IL-10-producing T R 1-like cells localized in the small intestine. 49 Similarly, nonallergic beekeepers and cat owners who are naturally exposed to continued antigenic stimulation develop high numbers of antigen-specific IL-10-secreting T R 1 cells, which control undesired T H 2 immune responses. 23, 50, 51 These findings suggest the importance of OIT to control food allergen responses through induction of T R 1 cells in the intestine. Development of food allergies is significantly influenced by the genetic background. Sicherer et al 52 estimated the heritability of PA at 81.6% when studying a cohort of monozygotic twins. In addition, genetic defects affecting different components of the immune response and resulting in gain of function of the IL-4, IL-9, IL-13, and TGF-b pathways have been linked to atopic diseases. [53] [54] [55] [56] Mutations of the HLA-DQ/DR 57 and FLG 58 genes have been specifically associated with peanut allergy. A novel line of evidence suggests that epigenetic defects play a role in food allergies because a differential CpG methylation profile has been observed in children allergic to egg, peanut, milk, and shrimp. 59, 60 We cannot exclude that the patients with PA in our study carry genetic or epigenetic defects in genes crucial for T R 1 cell generation and function.
Determining why anergy could be induced for pea-T10 cells of only a few patients with PA in our cohort is a crucial step in understanding peanut allergies and the mechanism of OIT. It should be considered that our experiments were performed starting with peripheral blood cells, which might not represent what is occurring in the gut, where chronic antigen exposure is taking place and where T R 1 cells preferentially home to. However, our data indicate that pea-T R 1 cells induced in our system might possess gut-homing abilities, as assessed by GPR15 and CCR9 expression. Studies are ongoing to test whether percentages and numbers of T R 1 cells increase over the course of OIT in the gut.
To conclude, our data show that pea-specific T R 1 cells can be induced toward the main peanut allergens Ara h 1 and 2 and that the presence of functional T R 1 cells is associated with inhibition of T H 2 responses in HC subjects but not in patients with PA. Therefore, we can hypothesize that providing functional peanutspecific T R 1 cells to patients with PA could facilitate the regulation of allergic responses. For this achievement, autologous pea-T R 1 cells could be generated by enforced lentivirusmediated expression of IL-10, which should overcome the limitations dictated by genetic or epigenetic predispositions in allergic patients. 61 
Key messages
d Peanut-specific T R 1 cells can be induced in vitro from HC subjects and patients with PA.
d T R 1 cell cultures induced in vitro from patients with PA, unlike those from HC subjects, are not anergic and have high T H 2 responses.
METHODS
Dendritic cell differentiation
CD14
1 monocytes were isolated from PBMCs by using a positive selection kit (Miltenyi Biotec, Bergisch Gladbach, Germany), according to the manufacturer's instructions. CD14 1 cells were differentiated into mDCs and DC10s, as previously described. E1 Briefly, CD14 1 cells were incubated for 7 days in RPMI 1640 (Life Technologies, Carlsbad, Calif) supplemented with 5% pooled AB human serum (Sigma-Aldrich, Saint Louis, Mo) and 100 U/mL penicillin/streptomycin (Life Technologies) in the presence of 10 ng/mL of recombinant human IL-4 (R&D Systems, Minneapolis, Minn) and 100 ng/mL of recombinant human GM-CSF, with addition of 10 ng/mL IL-10 (BD Biosciences, San Jose, Calif) to differentiate DC-10s. After 5 days, purified endotoxin-free Ara h 1 and 2 (Indoor Biotechnologies, Charlottesville, Va) or inactivated TT (EMD Millipore, Billerica, Mass) proteins were added for 2 days to the DCs (pea-mDC, pea-DC-10 and TT-mDC, respectively). The optimal concentration of the peptides was determined from a dose-response curve (0.1-20 mg/mL), testing the proliferation of autologous CD4 1 T cells. The optimal concentration of TT was 1 mg/mL and 10 mg/mL for Ara h 1 and 2. For each experiment, the maturation of the DC was confirmed by means of flow cytometry to determine the expression of CD11c, CD86 (BioLegend, San Diego, Calif), and CD14 (eBioscience, San Diego, Calif). DC established from a single blood donation were either used for primary stimulation or frozen and used later to test for antigen specificity or cytokine production.
T-cell differentiation 
Ara h 1/2-specific T-cell proliferation assay
To assess the proliferative response to a secondary antigen challenge, pea-Tm and pea-T10 cells were stained with carboxyfluorescein succinimidyl ester (Life Technologies) and plated alone (5 3 10 4 ) or with autologous peamDCs or TT-mDCs as a control (5 3 10 3 ) in complete medium in 96-well, round-bottom plates in a final volume of 200 mL. The percentage of divided cells within the CD3 1 CD4 1 T-cell population was assessed after 4 and 5 days.
Ara h 1/2 antigen specificity assay and cytokine detection
To assess the percentage of antigen-specific T R 1 cells, pea-T10 cells were plated alone (1 3 10 5 ) or with autologous pea-mDCs or TT-mDCs (1 3 10 4 ) in complete medium in 96-well, round-bottom plates in a final volume of 200 mL to assess the percentage of antigen-specific T R 1 cells. Expression of the activation markers CD69 and CD137 (BD Biosciences) was assessed by flow cytometry on gated CD3
1 CD4 1 CD45RA 2 T cells after 24 and 48 hours, respectively. The optimal stimulation time to assess the expression of these markers was determined by using a time-course experiment (12-72 hours). At 48 hours, supernatants were collected and frozen for analysis of cytokine detection. Levels of IL-4, IL-10, IFN-g, and GM-CSF in the supernatants of pea-Tm/pea-T10 cells and pea-mDC cocultures were assessed by ELISA (BD Biosciences).
Flow cytometry
For phenotyping of DC the samples were acquired using a Dxp10 FACScan (Cytek Dev, Fremont, Calif). For all other analyses, samples were acquired with a FACSAria (BD Biosciences). Staining of pea-Tm and pea-T10 cells was performed at 378C for 15 minutes (protocol based on Gagliani et al E2 ). All other stainings were performed according to the manufacturer's recommendations.
Statistical analyses
GraphPad Prism software (version 6.07; GraphPad Software, La Jolla, Calif) was used for statistical analyses. Results are presented as mean 6 SD, unless stated otherwise. We used Mann-Whitney test, Wilcoxon test, Spearman correlation test, and paired Student t test to determine the statistical significance of the data. P values of less than .05 were considered significant. For computing summary statistics, we considered the log value of pea-Tm/pea-T10 cell proliferation. (Fig E3, B) and comparison of PA cohorts (ST-OIT, n 5 7; LT-OIT, n 5 7; Fig E3, C) . Bas, Baseline. Means and SDs are shown. (Fig E4, B) and comparison of PA cohorts (Fig E4, C) . (Fig E5, A) and IFN-g (Fig E5, B) of HC subjects (left panels) and patients with PA (middle panels). Each symbol represents a single experiment. Right panels represent a comparison of all HC subjects and patients with PA; mean cytokine detection levels are shown. C-E, Scatter plots comparing levels of IL-4 (in picograms per milliliter; Fig E5, C) , IL-5 (in picograms per milliliter; Fig E5, D) , and IL-10 (in picograms per milliliter; Fig E5, E) (Fig E6, A) and CD137 (Fig E6, B) For each experiment, the number of samples tested is indicated. Anergy is indicated only when present.
